top of page
Audience In Theater

CEO

Edward Perello

Edward Perello is CEO of Humanity Biosciences, a next-gen biotech company launching a
longevity product portfolio and incubating assets across other biotech domains. He is a biologist,
serial entrepreneur and investor that has launched companies in Europe, United States and Latin
America. He led venture creation in agriculture & ecosystem services at Deep Science Ventures,
is an Johns Hopkins ELBI Biosecurity Fellow, a Stanford SynBio LEAP fellow, and formerly co-
founded and exited Desktop Genetics, a provider of CRISPR genome editing tools. He has
worked with corporate innovation, government funders and philanthropies to develop applied
science companies to transform the way humans produce food and impact nature, and has
launched agritech & sustainability venture building hubs and companies. 
Edward served on the IUCN Synthetic Biology and Gene Drive Taskforce and previously
worked in science & technology for the EU, the arms control charity VERTIC, and synthetic
biology competition iGEM In 2017 he was listed on the Forbes 30 Under 30.
He was Principal of Arkurity, a research consultancy working on critical issues at the interface of
public policy, biotechnology, and national and natural security, with clients including Google
DeepMind, Netflix, the Nuclear Threat Initiative and Revive & Restore. His byline appears in
Wired and Vice and he is a quirky public speaker.
Edward holds a BSc in Bioveterinary Science from London’s Royal Veterinary College and an
MPhil in Bioscience Enterprise from the University of Cambridge.

bottom of page